Record
Loading…
Record
Loading…
organization
Novo Nordisk is a Danish pharmaceutical company, headquartered in Bagsvaerd Denmark. Its CEO is Maziar Mike Doustdar, since . It reported revenue of 309.06B DKK for the period ended .
| fact | value | valid fromThe day the value took effect, not the day it was published. A period figure (a year's revenue) is dated at the period's end.More in About → | confidenceHow well the sources support the value, from 0 to 1. A single primary source is asserted from 0.7; nothing below 0.5 is asserted; a dead or disagreeing source lowers it.More in About → | sourcesPrimary: the entity's own filing, feed or site. Secondary: a publisher reporting it. Each claim links every source it has, with the passage that states the value where one was read.More in About → |
|---|---|---|---|---|
| total equity | 194,047,000,000 DKK | sec.gov: 1 source for total equity, claim clm_51EBABE50856 |
No dated events on the record yet.
Every claim on the timeline, including undated ones →No changes since .
The full timeline →"sameAs": ["https://www.wikidata.org/wiki/Q818846", "https://asof.is/record/novo-nordisk"],
"identifier": { "@type": "PropertyValue", "propertyID": "asof", "value": "ent_novo-nordisk" }